Experience of a mid-term care facility in the covid-19 with visit protocols
e202111171
Keywords:
COVID-19, SARS-CoV-2, COVID-19 prevention, Disease Transmission, Infectious, Non pharmaceutical Interventions (NPIs), Long Term Care Facilities, Mid-term Care Hospital, Healthcare Humanization (DDCS050250), Hospital Management (D006739), Hospital visitsAbstract
Background: The Hospital Virgen de la Poveda, (Villa del Prado, Spain), assists patients in need of Continuous medical care, Rehabilitation or Palliative care; these patients have many risk-factors of COVID-19 morbility and mortality. With both healthcare humanization and contagion-prevention purposes, in July 2020 two patient visit protocols were implemented. The objective of this study is to describe these measures qualitatively and quantitatively.
Methods: A context is provided regarding COVID-19 measures in this institution. The content and follow-up indicators of visit protocols (number of visits, of outbreaks, inpatients, etc.) and of their context were provided. The empirical outbreak probabilities were calculated, and hypothesis contrast was performed against no-visits (0%) and no visit-control (7-day cumulative incidence/habitant).
Results: Two protocols were created. Accompanying was applied to Palliative Care cases (no appointments required, no time limits), and a short visits protocol was applied to the other patients (appointments for 1 weekly visit for 1-2 persons were given and visits last up to 45 minutes). In both protocols, visitors with symptoms or fever or particularly susceptible were forbidden entrance. Between July and April 2021, 4,759 short-visit appointments were given and 7,544 total visits took place (short visits, accompanying, exceptions). An outbreak was possibly attributed to short visits (probability=0.021% [CI95%: 0.0005-0.1171%]) and two outbreaks were possibly attributed to visits globally (probability=0.0265% [IC95%: 0.0032-0.0958%]).
Conclusions: Elaborating adapted, applicable and prospectively-evaluated protocols with prevention measures at multiple levels might succeed in minimizing the risk of adverse events (in this case, COVID-19 outbreaks).
Downloads
References
Ministerio de Sanidad. Información científica-técnica. Enfermedad por coronavirus, COVID-19. https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/ITCoronavirus.pdf [Citado 09/11/2020].
Mondelli MU, Colaneri M, Seminari EM, Baldanti F, Bruno R. Low risk of SARS-CoV-2 transmission by
fomites in real-life conditions. The Lancet Infectious Diseases. 2021;21(5):e112. doi:10.1016/s1473-3099(20)30678-2
Hernández C. Coronavirus: primeras limitaciones a las visitas en hospitales españoles. 06/03/2020. Redacción Médica. https://www.redaccionmedica.com/secciones/sanidad-hoy/-coronavirus-primeras-limitaciones-a-las-visitas-en-hospitales-espanoles-6431 [Citado 13/11/2020].
Santillán-García A, Ferrer-Arnedo C. Consideraciones éticas durante las crisis sanitarias: A propósito de la pandemia por el coronavirus SARS-CoV-2. Rev Esp Salud Pública. 2020; 94: 6 de noviembre. e202011149.
World Health Organization. Preventing and managing COVID-19 across long-term care services. Policy brief. 24-july-2020. https://www.who.int/publications/i/item/WHO-2019-nCoV-Policy_Brief-Long-term_Care-2020.1 [Citado 09/11/2020].
Grupos de trabajo COVID-19 de la Comisión Delegada y del Comité Consultivo del Consejo Territorial de Servicios Sociales y del Sistema para la Autonomía y Atención a la Dependencia: informe del grupo de trabajo COVID-19 y residencies. https://www.mscbs.gob.es/ssi/imserso/docs/GTCOVID_19_RESIDENCIAS.pdf [Citado 27/04/2021].
Danis K, Fonteneau L, Georges S, Daniau C, Bernard-Stoecklin S et al (ECDC Public Health Emergency Team). High impact of COVID-19 in long-term care facilities, suggestion for monitoring in the EU/EEA, May 2020. Eurosurveillance. 2020;25(22). doi:10.2807/1560-7917.es.2020.25.22.2000956.
Iritani O, Okuno T, Hama D, Kane A, Kodera K, Morigaki K et al. Clusters of COVID ‐19 in long-term care hospitals and facilities in Japan from 16 January to 9 May 2020. Geriatr Gerontol Int. 2020;20(7):715-719. doi: 10.1111/ggi.13973
Canadian Institute for Health Information. Pandemic Experience in the Long-Term Care Sector. How Does Canada Compare With Other Countries?. Ottawa, ON: CIHI; 2020. https://www.cihi.ca/sites/default/files/document/covid-19-rapid-response-long-term-care-snapshot-en.pdf [Citado 10/11/2020].
Jones K, Mantey J, Washer L, Meddings J, Patel PK, Montoya A et al. When planning meets reality: COVID-19 interpandemic survey of Michigan Nursing Homes. Am J Infect Control. 2021; S0196-6553(21)00145-0. doi: 10.1016/j.ajic.2021.03.016
Eckardt P, Guran R, Hennemyre J, Arikupurathu R, Poveda J, Miller N et al. Hospital affiliated long term care facility COVID-19 containment strategy by using prevalence testing and infection control best practices. Am J Infect Control. 2020;48(12):1552-1555. doi: 10.1016/j.ajic.2020.06.215
Constantino-Shor C, Rani G, Olin S, Holmes C, Nasenbeny K. Containment of a COVID-19 Outbreak in an Inpatient Geriatric Psychiatry Unit. J Am Psychiatr Nurses Assoc. 2020;27(1):77-82. doi: 10.1177/1078390320970653
Centers for Disease Control and Prevention. Interim Infection Prevention and Control Recommendations to Prevent SARS-CoV-2 Spread in Nursing Homes. https://www.cdc.gov/coronavirus/2019-ncov/hcp/long-term-care.html [Citado 26/04/2021].
Instituto de Salud Carlos III / Ministerio de Sanidad. Estrategia de detección precoz, vigilancia y control de COVID-19. https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/COVID19_Estrategia_vigilancia_y_control_e_indicadores.pdf [Citado 30/04/2021].
R Core Team (2020). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/
Ministerio de Sanidad. Evaluación del riesgo de transmisión de SARS-CoV-2 mediante aerosoles. Medidas de prevención y recomendaciones. Documento técnico. https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/COVID19_Aerosoles.pdf [Citado 30/04/2021].
Arons MM, Hatfield KM, Reddy SC, Kimball A, James A, Jacobs JR et al. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med. 2020;382(22):2081-2090. doi: 10.1056/nejmoa2008457
Centers for Medicare & Medicaid Services. Nursing Home Visitation - COVID-19. 17 Septiembre 2020. https://www.cms.gov/files/document/qso-20-39-nh.pdf [Citado 23/11/2020].
Centers for Disease Control and Prevention. Updated Healthcare Infection Prevention and Control Recommendations in Response to COVID-19 Vaccination. https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-after-vaccination.html Actualización 10-marzo-2021 [Citado 27/04/2021].
Centro de Coordinación de Alertas y Emergencias Sanitarias. Dirección General de Salud Pública, Calidad e Innovación. Ministerio de Sanidad. Adaptación de las
medidas en residencias de mayores y otros centros de servicios sociales de carácter residencial en el marco de la vacunación (Documento Técnico). Fecha de 15-marzo-2021. https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/Centros_sociosanitarios_actuacion_vacunados.pdf [Citado 30/04/2021
Li S, Li J-Z, Chen Y-W, Bai X-W, Ren X-P, Zheng R et al. Can Overconfidence be Debiased by Low-Probability/High-Consequence Events? Risk Analysis . 2010;30(4):699-707. doi: 10.1111/j.1539-6924.2010.01371.x
Lelieveld J, Helleis F, Borrmann S, Cheng Y, Drewnick F, Haug G et al. Model Calculations of Aerosol Transmission and Infection Risk of COVID-19 in Indoor Environments. IJERPH. 2020;17(21):8114. doi:10.3390/ijerph17218114
Druică E, Musso F, Ianole-Călin R. Optimism Bias during the Covid-19 Pandemic: Empirical Evidence from Romania and Italy. Games . 2020;11(3):39. doi: 10.3390/g11030039
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Luis Alfredo Bautista Balbás, Olga Velasco Guijarro, Rosa Sandino Gómez, Mercedes Rosado Palacios, Mario Gil Conesa, Violeta Cordero Castrejón, Raquel Gil Rosado, Paloma López Moraleda, Fernando Palacios Agrela, Beatriz Pérez Parras, Gil Rodríguez Caravaca
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
![¿Cómo evaluar para la RESP? [PARA REVISORES]](https://ojs.sanidad.gob.es/public/site/images/rmartinb/pastilla-revisores-0eaa113abcbc4fc554c7c6c7840ca4c6.jpg)
![¿Cómo recibir avisos sobre nuevos artículos de la RESP? [PARA LECTORES]](https://ojs.sanidad.gob.es/public/site/images/rmartinb/pastilla-lectores-aa689338e95aab07df45b4b0d583188f.jpg)
